Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - ALNYLAM PHARMACEUTICALS, INC. | Financial_Report.xls |
EX-32.2 - EX-32.2 - ALNYLAM PHARMACEUTICALS, INC. | d754022dex322.htm |
EX-10.2 - EX-10.2 - ALNYLAM PHARMACEUTICALS, INC. | d754022dex102.htm |
EX-31.2 - EX-31.2 - ALNYLAM PHARMACEUTICALS, INC. | d754022dex312.htm |
EX-10.1 - EX-10.1 - ALNYLAM PHARMACEUTICALS, INC. | d754022dex101.htm |
EX-31.1 - EX-31.1 - ALNYLAM PHARMACEUTICALS, INC. | d754022dex311.htm |
EX-10.4 - EX-10.4 - ALNYLAM PHARMACEUTICALS, INC. | d754022dex104.htm |
EX-10.6 - EX-10.6 - ALNYLAM PHARMACEUTICALS, INC. | d754022dex106.htm |
EX-10.3 - EX-10.3 - ALNYLAM PHARMACEUTICALS, INC. | d754022dex103.htm |
EX-10.5 - EX-10.5 - ALNYLAM PHARMACEUTICALS, INC. | d754022dex105.htm |
10-Q - FORM 10-Q - ALNYLAM PHARMACEUTICALS, INC. | d754022d10q.htm |
EX-32.1 - EX-32.1 - ALNYLAM PHARMACEUTICALS, INC. | d754022dex321.htm |
Exhibit 12
STATEMENT REGARDING COMPUTATION OF CONSOLIDATED RATIOS OF EARNINGS/DEFICIENCIES TO FIXED CHARGES
(dollars in thousands)
Fiscal Year Ended December 31, | ||||||||||||||||||||||||||||
Six Months Ended June 30, 2014 |
Three Months Ended June 30, 2014 |
2013 | 2012 | 2011 | 2010 | 2009 | ||||||||||||||||||||||
Earnings (loss): |
||||||||||||||||||||||||||||
Pre-tax loss from continuing operations before adjustment for loss from equity investee |
$ | (313,202 | ) | $ | (44,389 | ) | $ | (91,920 | ) | $ | (112,064 | ) | $ | (54,144 | ) | $ | (35,362 | ) | $ | (42,098 | ) | |||||||
add: Fixed charges (see below) |
734 | 506 | 678 | 1,188 | 1,207 | 1,207 | 712 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Pre-tax loss from continuing operations before adjustment for income/loss from equity investees plus fixed charges |
$ | (312,468 | ) | $ | (43,883 | ) | $ | (91,242 | ) | $ | (110,876 | ) | $ | (52,937 | ) | $ | (34,155 | ) | $ | (41,386 | ) | |||||||
Fixed charges: |
||||||||||||||||||||||||||||
Interest expense on portion of rent expense representative of interest |
$ | 734 | $ | 506 | $ | 678 | $ | 1,188 | $ | 1,207 | $ | 1,207 | $ | 712 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total fixed charges |
$ | 734 | $ | 506 | $ | 678 | $ | 1,188 | $ | 1,207 | $ | 1,207 | $ | 712 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Ratio of earnings to fixed charges |
| | | | | | | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Deficiency of earnings available to cover fixed charges |
$ | (313,202 | ) | $ | (44,389 | ) | $ | (91,920 | ) | $ | (112,064 | ) | $ | (54,144 | ) | $ | (35,362 | ) | $ | (42,098 | ) | |||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|